Vyro Biotherapeutics

@vyrobio

Vyro is developing a first-in-class oncolytic Zika viral (oZIKV) immunotherapy for the treatment of malignant CNS tumors.
Followers
1,020
Following
99
Account Insight
Score
25.59%
Index
Health Rate
%
Users Ratio
10:1
Weeks posts

@vyrobio Instagram Profile Picture in Full Size HD and DP Photo

@vyrobio